The term biofabrication describes natural processes such as biomineralization; also technological processes in various disciplines such as catalysis, biotechnology, sensing, synthetic biology, and especially tissue engineering (TE) and regenerative medicine (RM). Within TE and RM, biofabrication can generally be divided into two distinct approaches: bioprinting and bioassembly.

Biofabrication is a rapidly growing field of research that continues to develop and is outgrowing its infancy. This is partially due to the expiration of patents covering fused deposition modeling, which has rapidly made Additive Manufacturing equipment, commonly known as three-dimensional (3D)-printing, more affordable and widely available. In concert with this lowered cost of equipment has been the transformation of rapid prototyping into rapid manufacturing. A similar evolution and expansion of applications has occurred in Biofabrication especially for the fields of Tissue Engineering (TE).

The US Defence Advanced Research Projects Agency used the definition 'Biofabrication—the use of biological materials and mechanisms for construction' to describe methods used to create high-resolution 3D structures that mimic biological growth mechanisms.

Today, the term Biofabrication is broadly used in the context of fabricating organic/inorganic hybrid materials or, more generally, fabrication of materials by living organisms. Within the TE community, the term Biofabrication emerged with the application of 3D manufacturing strategies incorporating the manipulation and positioning of living cells and/or cell aggregates.

At FUROID™️ we have the advantages that we are not bound on certain GMP/GLP criteria’s to achieve the desired fur/wool tissue features since our application is for the industrial use and not for the use in medicine applications.